538 related articles for article (PubMed ID: 2460749)
1. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells.
Weaver CA; Springer PA; Katzenellenbogen BS
Mol Endocrinol; 1988 Oct; 2(10):936-45. PubMed ID: 2460749
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
3. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells.
Hurd C; Dinda S; Khattree N; Moudgil VK
Oncogene; 1999 Jan; 18(4):1067-72. PubMed ID: 10023683
[TBL] [Abstract][Full Text] [Related]
5. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
6. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
7. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum.
Moore M; Mustain M; Daniel K; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jan; 142(1):160-8. PubMed ID: 9007045
[TBL] [Abstract][Full Text] [Related]
9. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
Herman ME; Katzenellenbogen BS
J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel transferable cis element in the promoter of an estrogen-responsive gene that modulates sensitivity to hormone and antihormone.
Montano MM; Kraus WL; Katzenellenbogen BS
Mol Endocrinol; 1997 Mar; 11(3):330-41. PubMed ID: 9058379
[TBL] [Abstract][Full Text] [Related]
11. Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence.
Fujimoto N; Katzenellenbogen BS
Mol Endocrinol; 1994 Mar; 8(3):296-304. PubMed ID: 7517003
[TBL] [Abstract][Full Text] [Related]
12. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.
Jeng MH; Langan-Fahey SM; Jordan VC
Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763
[TBL] [Abstract][Full Text] [Related]
13. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen and ZK 119010 exert mixed agonistic and antagonistic effects on pS2 expression in MCF-7 cells.
Schütze N; Schneider MR; Knuppen R; Vollmer G
Cancer Detect Prev; 1994; 18(6):479-83. PubMed ID: 7867021
[TBL] [Abstract][Full Text] [Related]
15. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
[TBL] [Abstract][Full Text] [Related]
16. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
Chalbos D; Philips A; Galtier F; Rochefort H
Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
Duan R; Porter W; Safe S
Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985
[TBL] [Abstract][Full Text] [Related]
18. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
Jeng MH; Parker CJ; Jordan VC
Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
[TBL] [Abstract][Full Text] [Related]
19. The influence of antiestrogens on pS2 and cathepsin D mRNA induction in MCF-7 breast cancer cells.
Rajah TT; Dunn ST; Pento JT
Anticancer Res; 1996; 16(2):837-42. PubMed ID: 8687138
[TBL] [Abstract][Full Text] [Related]
20. Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms.
Demirpence E; Balaguer P; Trousse F; Nicolas JC; Pons M; Gagne D
Cancer Res; 1994 Mar; 54(6):1458-64. PubMed ID: 8137248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
